Assisted Reproductive Technology in Autism Spectrum Disorders
Since the world’s first test-tube baby was born in 1978, assisted reproductive technology (ART) has continued to be developed, resulting in the birth of estimated four million babies by ART, worldwide. The recent large-scale twin study in autism spectrum disorders (ASD) suggested that the contribution of early environmental factors is stronger than that was thought before. As such environmental factors, ART is one of the candidates. On the other hand, the prevalence of ASD has increased dramatically over the last decades; meanwhile the use of ART has also increased rapidly. Therefore, association between this increase in ASD prevalence and the increase in ART procedures has been suggested. Contradictory results have been reported concerning a possible correlation between ART and ASD, and the existence of such an association remains unclear. About the risk of attention deficit and hyperactivity disorder (ADHD) in ART children, a national registry study has found the weak but statistically significant association. Similarly, another national registry study has found the statistically significant associated of ART with broad range of psychiatric conditions including ASD and ADHD. The large-scale follow-up study of ART children that clarifies factors associated with increased risk of developmental disorders including ASD is very important for the development of better ART procedures. We hope that ART becomes an increasingly safe and effective therapy for infertile couples.
KeywordsSchizophrenia Stein Hypoglycemia Infertility Endometriosis
- ART Registry of Japan, 2007. http://plaza.umin.ac.jp/∼jsog-art/data.htm of subordinate document; 2009. Accessed 11 Nov 2012.Google Scholar
- Barnes J, Sutcliffe AG, Kristoffersen I, Loft A, Wennerholm U, Tarlatzis BC, Kantaris X, Nekkebroeck J, Hagberg BS, Madsen SV, Bonduelle M. The influence of assisted reproduction on family functioning and children’s socio-emotional development: results from a European study. Hum Reprod. 2004;19:1480–7.PubMedCrossRefGoogle Scholar
- Bhattacharya S, Harrild K, Mollison J, Wordsworth S, Tay C, Harrold A, McQueen D, Lyall H, Johnston L, Burrage J, Grossett S, Walton H, Lynch J, Johnstone A, Kini S, Raja A, Templeton A. Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial. BMJ. 2008;337:a716.PubMedCrossRefGoogle Scholar
- Bonduelle M, Wennerholm UB, Loft A, Tarlatzis BC, Peters C, Henriet S, Mau C, Victorin-Cederquist A, Van Steirteghem A, Balaska A, Emberson JR, Sutcliffe AG. A multi-centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception. Hum Reprod. 2005;20:413–19.PubMedCrossRefGoogle Scholar
- Centers for Disease Control and Prevention. 2007 assisted reproductive technology report. http://www.cdc.gov/art/ART2007/index.htm of subordinate document; 2009. Accessed 11 Nov 2012.
- Dupont C, Sifer C. A review of outcome data concerning children born following assisted reproductive technologies. Obstet Gynecol. 2012; ISRN 405382.Google Scholar
- Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, Fedele A, Collins J, Smith K, Lotspeich L, Croen LA, Ozonoff S, Lajonchere C, Grether JK, Risch N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68:1095–102.PubMedCrossRefGoogle Scholar
- Hvidtjorn D, Grove J, Schendel D, Schieve LA, Svaerke C, Ernst E, Thorsen P. Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study. J Epidemiol Community Health. 2011;65(6):497–502. doi: 10.1136/jech.2009.093823. Epub 2010 Jun 27.PubMedCrossRefGoogle Scholar
- Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Wong WS, Sigurdsson G, Walters GB, Steinberg S, Helgason H, Thorleifsson G, Gudbjartsson DF, Helgason A, Magnusson OT, Thorsteinsdottir U, Stefansson K. Rate of de novo mutations and the importance of father’s age to disease risk. Nature. 2012;488:471–5.PubMedCrossRefGoogle Scholar
- Shimada T, Kitamoto A, Todokoro A, Ishii-Takahashi A, Kuwabara H, Kim S-Y, Watanabe K, Minowa I, Someya T, Ohtsu H, Osuga Y, Kano Y, Kasai K, Kato N, Sasaki T. Parental age and assisted reproductive technology in autism spectrum disorders, attention deficit hyperactivity disorder, and Tourette syndrome in a Japanese population. Res Autism Spectr Disord. 2012;6:500–7.CrossRefGoogle Scholar
- Soini S, Ibarreta D, Anastasiadou V, Ayme S, Braga S, Cornel M, Coviello DA, Evers-Kiebooms G, Geraedts J, Gianaroli L, Harper J, Kosztolanyi G, Lundin K, Rodrigues-Cerezo E, Sermon K, Sequeiros J, Tranebjaerg L, Kaariainen H. The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. Eur J Hum Genet. 2006;14:588–645.PubMedCrossRefGoogle Scholar
- The Official Web Site of the Nobel Prize. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2010/ of subordinate document; 2010. Accessed 11 Nov 2012.
- Wang YA, Chambers G, Dieng M, Sullivan EA. Assisted reproductive technology in Australia and New Zealand 2007. Assisted reproduction technology series no. 2013. Cat. no. PER 2047. Canberra: AIHW; 2009. http://www.aihw.gov.au/publication-detail/?id=6442468283 of subordinate document. Accessed 11 Nov 2012.
- WHO Technical Report Series. Recent advances in medically assisted conception number 820; 1992. p. 1–111.Google Scholar